Search for a podcast, browse episodes, and download MP3 files directly from the publisher's website. Every episode comes with a downloadable transcript - we generate one if the show doesn't provide it.

In this podcast, Margaret Maglione, MPP, discusses a rapid review of adult ADHD stimulant medication misuse in the United States. The review synthesizes evidence from 64 studies and examines recent trends in misuse, demographic patterns, routes of acquisition, and associated consequences. Although…

In this podcast, Dr. Holly Geyer, an internal medicine and addiction medicine specialist at Mayo Clinic, interviews Dr. Andrew Kolodny, an addiction psychiatrist and Medical Director of the Opioid Policy Research Collaborative at Brandeis University, about his Journal of Clinical Psychopharmacology…

In this podcast, Drs Balwinder Singh and Liliana Patarroyo-Rodriguez discuss their case report of lithium toxicity in a patient with bipolar I disorder who had obtained tirzepatide online without clinician supervision. Tirzepatide is a GLP-1 medication that the patient sought for weight management.…

in this podcast, Dr. Julia Ann Koretski, Digital Editor of the Journal of Clinical Psychopharmacology, leads a discussion of an editorial authored by Giovanni A. Fava, Steven L. Dubovsky, and Richard Balon. Drs Fava and Dubovsky, both form the University at Buffalo, and Dr. Balon, from Wayne State…

Serotonin reuptake inhibitors (SRIs) are a common treatment for major depressive disorder, but they are inadequate for many patients. An article published in the July-August 2026 issue reviews decades of evidence suggesting that their effects may be improved by developing medications, based on…

Bremelanotide (Vyleesi) was approved by the US Food and Drug Administration in 2019 as an on-demand subcutaneous injectable for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. An editorial in the May-June 2026 issue of the Journal of Clinical Psychopharmacology…

Why can it be challenging to find a psychiatrist well-trained in psychopharmacology? An editorial in the March-April 2026 issue of the Journal of Clinical Psychopharmacology suggests that the problem is not just an overall shortage of psychiatrists but also deficiencies in the depth of training,…

In this podcast, Orges Alabaku discusses his article, "The Use of VMAT2 Inhibitors for Tardive Dyskinesia," which is published in the March-April 2026 issue of the Journal of Clinical Psychopharmacology. As Dr. Albaku notes, tardive dyskinesia (TD) is a potentially severe and often persistent…

In youth, binge eating is often marked by loss of control eating (LOC-E), defined as difficulty stopping eating and persistent, compulsive food-seeking behaviors that occur even in the absence of physical hunger. In this podcast, Dr. Aaron Keshen discusses his article, titled, "Reduction of Loss of…

Treatment-resistant depression (TRD) is a considerable clinical challenge. Esketamine, in conjunction with an oral antidepressant, is a potential treatment for TRD. In this podcast, Dr. Matteo Lupi discusses his article, "Esketamine and Quality of Life Improvement in Treatment-Resistant Depression…

Atomoxetine is a selective norepinephrine reuptake inhibitor prescribed for the management of attention-deficit hyperactivity disorder (ADHD). In this podcast, Emily Yamada discusses her article "Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers: Evidence From Human Milk…

As interest grows in the therapeutic potential of ketogenic diets for bipolar disorder, careful attention must be given to drug-diet interactions. Overlapping mechanisms between therapeutic ketosis and mood-stabilizing agents may offer opportunities for synergistic effects, but may also introduce…